Sana Biotechnology
Senior MSAT Engineer supporting Sana’s stem cell-derived pancreatic islet cell program (SC451) to prepare manufacturing for phase 1 clinical trials. The role partners with Research and manufacturing teams to translate and scale processes, lead technology transfers to external CDMOs, and provide on-site manufacturing support. The position emphasizes working in regulated, cGMP environments and contributing to documentation and regulatory materials.
Headquarters
Seattle, Washington, United States
Company Size
201-500 employees
Founded
2018
Sana Biotechnology engineers cells to repair or control genes in diseased cells or to replace missing or damaged cells, aiming to address the underlying causes of disease. The company develops cell- and gene-based therapeutic platforms — spanning in vivo and ex vivo approaches — to create durable, curative treatments across a range of indications. Sana combines platform R&D with preclinical and clinical programs to advance engineered-cell medicines toward scalable, restorative therapies.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Sana Biotechnology.
Sana Biotechnology to Present at March 2026 Investor Conferences
3 weeks ago
Junior Postdoctoral Fellow
Salk Institute
Research Specialist
University of Wisconsin–Madison
Research Assistant - Joslin Diabetes Center
Beth Israel Lahey Health
Postdoctoral Researcher – iPSC-Derived Liver Cell Engineering
Terasaki Institute for Biomedical Innovation
Postdoctoral Scientist - Alvarez Lab
Howard Hughes Medical Institute
Scientist
Mytos